Brief: Oncternal Therapeutics Q1 Net Income USD -8.388 Million
09/05/2024 21:01
May 09 (Reuters) - Oncternal Therapeutics Q1 income from operations USD -8.779 million. * Q1 operating expenses USD 9.348 million * Q1 basic EPS USD -2.83
Recent news on Oncternal Therapeutics
See all newsOncternal Therapeutics Inc expected to post a loss of $3.19 a share - Earnings Preview
Brief: Oncternal Therapeutics Workforce Reduction Of About 10 Employees
U.S. STOCKS ON THE MOVE-Unity Software, Viking Holdings, Adobe
U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Warner Bros Discovery
Oncternal hits record low on plans to scrap studies, explore strategic alternatives;